

Ahammune Biosciences - Total Funding, Funding Over Time, Funding By Rounds and More
Founded in 2016, Ahammune Biosciences operates in Health Tech industry. Initially concentrating on therapeutic solutions for vitiligo, the company has expanded its research and development efforts to ...
Funding stage:
Series A
Last funding:
24/09/2024
Total funding:
$5.00 Mn+
Revenue:
Investors
Employee count:
11
Last 90d
11
Last 90d
Web traffic:
1.35K
1.35K
Last 30d
Last 30d
Ahammune Biosciences: Funding Highlights
Funding highlights of Ahammune Biosciences and a snapshot of its key metrics.
- Total Funding$5.00 Mn+
- Current StageGrowth Stage
- Total Round(s)2
Funding Rounds
FAQs on Funding of Ahammune Biosciences
Health Tech Funded Ahammune Biosciences has raised a total funding of $5.00 million dollars as of 25 September 2024 across 2 rounds. Find the details around funding rounds, participating investors, and other insights of Ahammune Biosciences here...
Ahammune Biosciences has raised a total of $5.00 million dollars across 2 funding rounds and the last round was raised on 25 September 2024.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links